ask="9.60"
ask_size="200"
average_daily_volume="309570"
bid="5.14"
bid_size="100"
book_value="1.77"
change="+0.14"
change_from_200_day_moving_average="0.19"
change_from_50_day_moving_average="-0.57"
change_from_52_week_high="-1.79"
change_From_52_week_low="2.28"
change_in_percent="+1.53%"
close="9.28"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.60"
ebitda="-135.66M"
eps_estimate_current_year="-1.67"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-3.10"
ex_dividend_date="N/A"
float_shares="14521000"
high="9.45"
high_52_weeks="11.07"
last_trade_date="3/15/2017"
last_trade_price="9.28"
last_trade_size="8853"
last_trade_time="4:00pm"
low="9.10"
low_52_weeks="7.00"
market_capitalization="169.82M"
moving_average_200_day="9.09"
moving_average_50_day="9.85"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="9.16"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.04%"
percent_change_from_50_day_moving_average="-5.76%"
percent_change_from_52_week_high="-16.17%"
percent_change_from_52_week_low="+32.57%"
previous_close="9.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.17"
price_per_sales="108.97"
revenue="1.53M"
shares_outstanding="18300000"
short_ratio="8.41"
stock_exchange="NGM"
symbol="AKBA"
volume="198664"
weeks_range_52="7.00 - 11.07"
